LON:VRCI Verici Dx (VRCI) Share Price, News & Analysis GBX 6.75 0.00 (0.00%) (As of 09/6/2024 ET) Add Compare Share Share Today's Range 6.72▼ 6.7550-Day Range 6.24▼ 852-Week Range 5.50▼ 13Volume500 shsAverage Volume343,260 shsMarket Capitalization£16.37 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsStock AnalysisChartCompetitors Get Verici Dx alerts: Email Address Ad Golden CrestBiden's Successor: The Radical Threat to YOUR Savings!Kamala Harris isn't just playing politics; she's a serious threat to your financial security. Kamala has a plan to take over your money and leave you with nothing. Higher taxes, government control, and a digital dollar to track every penny you spend. This isn't about convenience; it's about CONTROL.>> Get Your FREE Wealth Protection Guide << About Verici Dx Stock (LON:VRCI)Verici Dx plc, an immuno-diagnostics development company, focuses on the kidney transplantation market. The company develops prognostic and diagnostic tests for kidney transplant patients. Its lead products comprise Tutivia, a post-transplant test focused on acute rejection, including sub-clinical rejection; and Clarava, a pre-transplant prognosis test for the risk of early acute rejection. The company also develops Protega, a peripheral blood-based test that aims to predict the risk of fibrosis and long-term graft failure. Verici Dx plc was incorporated in 2020 and is based in Penarth, the United Kingdom.Read More VRCI Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart VRCI Stock News HeadlinesFebruary 24, 2024 | morningstar.comVerici Dx PLC Ordinary Shares VRCIFebruary 1, 2024 | morningstar.comVerici Dx PLC Ordinary SharesSeptember 7, 2024 | Timothy Sykes (Ad)Tim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT about Trump or Biden dropping out of the race…November 10, 2023 | finance.yahoo.comVerici Dx plc (63V.F)July 25, 2023 | finance.yahoo.comCompanies Like Verici Dx (LON:VRCI) Could Be Quite RiskyMay 25, 2023 | finance.yahoo.comDX - Dynex Capital, Inc.February 16, 2023 | finance.yahoo.comCloud DX Announces Private Placements of up to an Aggregate of $5.5 Million with Lead Orders of $1.5 MillionFebruary 15, 2023 | finance.yahoo.comWe're Keeping An Eye On Verici Dx's (LON:VRCI) Cash Burn RateSeptember 7, 2024 | Timothy Sykes (Ad)Tim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT about Trump or Biden dropping out of the race…January 18, 2023 | benzinga.comDynex Cap Stock (NYSE:DX), Quotes and News SummarySeptember 8, 2022 | finance.yahoo.comWe Think Verici Dx (LON:VRCI) Needs To Drive Business Growth CarefullySeptember 3, 2022 | uk.finance.yahoo.comVerici Dx plc (VRCI.L)June 14, 2022 | marketwatch.comVerici Releases Data on Tuteva Blood Test; Shares DiveMay 5, 2022 | finance.yahoo.comAmerican Shared Hospital Services Announces First Quarter 2022 Earnings Conference CallApril 9, 2022 | lse.co.ukVerici Dx Share ChatMarch 26, 2022 | investing.comVerici Dx Plc (VRCI)See More Headlines Receive VRCI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Verici Dx and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeLON SectorMedical Industry Diagnostics & Research Sub-IndustryN/A Current SymbolLON:VRCI CUSIPN/A CIKN/A Webwww.vericidx.com Phone44 207 9338780FaxN/AEmployees14Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)GBX (0.02) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income£-4,810,000.00 Net Margins-110.99% Pretax MarginN/A Return on Equity-58.12% Return on Assets-26.14% Debt Debt-to-Equity Ratio4.65 Current Ratio4.54 Quick Ratio8.49 Sales & Book Value Annual Sales£4.33 million Price / Sales3.78 Cash FlowGBX 5.14 per share Price / Cash Flow1.31 Book ValueGBX 4 per share Price / Book1.69Miscellaneous Outstanding Shares242,540,000Free FloatN/AMarket Cap£16.37 million OptionableNot Optionable Beta1.59 7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed InvestorsAs the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.Get This Free Report Key ExecutivesMs. Sara Barrington A.C.A. (Age 57)A.C.I.M., CEO & Executive Director Comp: $283.32kMr. David M. Anderson (Age 61)Chief Financial Officer Mr. Salim Gulamabbas Hamir F.C.A.Company SecretaryKey CompetitorsANGLELON:AGLAbingdon HealthLON:ABDXYourgene HealthLON:YGENgenedriveLON:GDRGENinCodeLON:GENIView All Competitors VRCI Stock Analysis - Frequently Asked Questions How have VRCI shares performed this year? Verici Dx's stock was trading at GBX 9.75 on January 1st, 2024. Since then, VRCI stock has decreased by 30.8% and is now trading at GBX 6.75. View the best growth stocks for 2024 here. How do I buy shares of Verici Dx? Shares of VRCI stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.Compare Top Brokerages Here. This page (LON:VRCI) was last updated on 9/7/2024 by MarketBeat.com Staff From Our PartnersPerfect Crypto Buying Opportunity for 50 CentsWhen cryptos take a hit, the mom and pop investors run for the hills. But the top investors keep buying wit...Crypto 101 Media | SponsoredThe solution to fast food’s wage hike crisisShake Shack will be closing six California locations in response to the recent $20/hour minimum wage increase,...Deal Maker | SponsoredPre-IPO| 32,481% Growth: First Disruption to $martphones in 15 Years🤳45M Users | 32,481% Growth Rate Get in on the biggest disruption to smartphones in over a decade. Reg A inv...Mode Mobile | SponsoredBiden’s Capital Gains Tax to Devastate Savings!Don't let the corrupt elites dictate your future—ACT NOW! This guide is your first step towards financial inde...Golden Crest | SponsoredSay Goodbye to the US DollarThe warning signs are everywhere… According to experts, the United States Dollar is "as good as doomed." ...Sasco Gold LLC | SponsoredChina Stockpiling Gold “Like No Tomorrow”For 18 consecutive months, China’s central bank has increased its gold reserve. The country, with a populat...True Gold Republic | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredTrump’s weapon lurks in abandoned AmericaUnemployment is sky-high, wages are at record lows. Addiction has overwhelmed these once thriving coal towns. ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Verici Dx plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Verici Dx With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.